Vera Therapeutics announces $100M follow-on public offering of 14.3M shares at $7.00/share

Vera Therapeutics, Inc.

Underwriting agreement signed for 14,285,715 shares of Class A common stock at $7.00 per share.
Gross proceeds of approximately $100 million before underwriting discounts and offering expenses.
Closing expected February 6, 2023; underwriters have 30-day option for 2,142,857 additional shares.
Lead underwriters: J.P. Morgan, Cowen, and Evercore.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.